Parameter
| Biomarker | APOE ε4 | Full name | Apolipoprotein E ε4 allele | Molecular Type | Nucleic acid (DNA) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Susceptibility | ||
| Disease | Acute pancreatitis (AP) | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Whole blood (genotyping) | ||
| Pathobiological Mechanisms | Influence of lipid metabolism, reduce A beta removal efficiency, carriers AP related neurological complications increased risk and the time in advance | ||||
| Clinical Availability Status | Clinical available (risk assessment) : conventional genetic tests available, but only for risk assessment, not for diagnosis, involves ethical issues | ||||
| Notes and Dynamics | It is the core variable in establishing the risk stratification model of neurological complications of AP. Important stratification factor is related to treatment trials | ||||